Germline RBBP6 mutations in familial myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Germline RBBP6 mutations in familial myeloproliferative neoplasms

Published:2016-01-21 Issue:3 Volume:127 Page:362-365
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Harutyunyan Ashot S.¹^ORCID,Giambruno Roberto¹,Krendl Christian¹,Stukalov Alexey¹,Klampfl Thorsten¹,Berg Tiina¹,Chen Doris¹,Milosevic Feenstra Jelena D.¹^ORCID,Jäger Roland¹,Gisslinger Bettina²,Gisslinger Heinz²,Rumi Elisa³,Passamonti Francesco⁴,Pietra Daniela³,Müller André C.¹,Parapatics Katja¹,Breitwieser Florian P.¹,Herrmann Richard⁵,Colinge Jacques¹,Bennett Keiryn L.¹,Superti-Furga Giulio¹,Cazzola Mario³,Hammond Emma⁶,Kralovics Robert¹²

Affiliation:

1. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;

2. Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;

3. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy;

4. Department of Internal Medicine, Division of Hematology, University Hospital, Ospedale di Circolo, Varese, Italy;

5. School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia; and

6. Institute of Immunology and Infectious Diseases, Murdoch University, Perth, Australia

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/3/362/1393342/362.pdf

Reference25 articles.

1. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease.;Kralovics;Blood,2003

2. JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.;Rumi;Cancer,2006

3. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders.;Bellanné-Chantelot;Blood,2006

4. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.;Landgren;Blood,2008

5. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.;James;Nature,2005

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes;Leukemia Research;2024-08

2. Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3′ ends;RNA;2024-07-10

3. Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes;HemaSphere;2024-07

4. Germline Predisposition in Hematologic Malignancies;Comprehensive Hematology and Stem Cell Research;2024

5. BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera;Physiology International;2023-09-05